简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

NextPlat Unveils AI-Powered ClearMetrX 4.0 To Boost Healthcare Efficiency

2025-09-23 20:07

Enhanced Software Suite to Feature AI-Assisted Analytics and Insights Designed to Support Greater Efficiency in Healthcare Operations While Driving Improved Patient Adherence and Outcomes

HALLANDALE BEACH, Fla., Sept. 23, 2025 /PRNewswire/ -- NextPlat Corp (NASDAQ:NXPL) (NASDAQ:NXPLW) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide, today announced that its ClearMetrx subsidiary has commenced late-stage development of ClearMetrX 4.0, the next generation of its proprietary healthcare data analytics and reporting software featuring a full range of artificial intelligence (AI)-enhanced capabilities. ClearMetrX 4.0 is expected to be rolled out internally in Q4, 2025. The Company intends to commercialize the software for new and existing customer deployments in the first half of 2026.

ClearMetrX is a cloud-based, end-to-end reporting platform that streamlines data analytics for physicians, management services organizations (MSOs), 340B entities, and pharmacies, and is actively used across the Company's pharmacies and client network. ClearMetrX 4.0 will integrate an array of AI-powered enhancements into the software, designed to increase its value as a comprehensive decision-support system, enabling a more streamlined way to collect, analyze and operationalize organizational healthcare data. According to Grandview Research, the global AI in healthcare market size was estimated at USD 26.57 billion in 2024 and is projected to reach USD 187.69 billion by 2030, growing at a CAGR of 38.62% from 2025 to 2030. A key factor driving market growth is the increasing demand in the healthcare sector for enhanced efficiency, accuracy, and better patient outcomes.

Birute Norkute, Vice President of Healthcare Operations at NextPlat, said, "Since its introduction, ClearMetrX has demonstrated its capabilities to positively impact not only the business of healthcare for us and a growing list of customers, but importantly, support better outcomes through improved patient adherence. With ClearMetrX 4.0, we are honoring our commitment to harness the power of technology such as AI to further improve the efficiency and effectiveness of healthcare to the benefit of all stakeholders."

Highlighted features of ClearMetrX 4.0 include:

  • Revenue Forecasting: Utilizing AI/ML models to predict revenue, prescription volumes, and patient demand with accuracy.
  • Predictive Inventory Management: Intelligent AI forecasting to optimize stock levels and reduce shortages or waste.
  • Anomaly & Exception Detection: Real-time AI tools to spot abnormal prescribing, dispensing, or claims patterns.
  • Audit Assistance, Analytics & Reporting: AI-powered dashboards that automate evidence gathering, compliance reporting, and deliver actionable analytics.
  • Fraud Detection: Advanced AI analytics to identify suspicious billing or dispensing activity.
  • What-If Simulations: AI-driven scenario models to evaluate financial and compliance outcomes.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。